Pet Cancer Therapeutics Market Size, Demand and Business Opportunities With Key Players Analysis 2028

IMARC Group has recently released a new research study titled “Pet Cancer Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028“, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

How big is the pet cancer therapeutics market?

The global pet cancer therapeutics market size reached US$ 268.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 473.1 Million by 2028, exhibiting a growth rate (CAGR) of 9.97% during 2023-2028.

Report Coverage:

Market Outlook:

Pet cancer therapeutics represent the diagnosis and treatment alternatives for tumor and cancerous growth in domesticated animals. It involves the treatment of mast cell cancer, melanoma lymphoma, and mammary and squamous cell cancer in cats, dogs, and other pet animals. Commonly used pet cancer therapeutics include immunotherapy, radiation therapy, chemotherapy, and biopsy. These cures gradually shrink or neutralize the cancer cells using plant- and bacteria-based drugs and stop the tumor from affecting other body parts. The drugs are injected intravenously or administered orally, under the skin, or into the cancer or a muscle. The medicines are mixed with the food or treat to hide the flavor and make it more appealing to the animals. Pet cancer therapeutics find widespread applications across veterinary hospitals, clinics, and retail and online pharmacies.

Request for a free sample copy of this report: https://www.imarcgroup.com/pet-cancer-therapeutics-market/requestsample

Market Trends:

The escalating prevalence of tumors in animals across the globe is among the primary factors driving the pet cancer therapeutics market. Besides this, the presence of leukemia and lymphoma in certain breeds of aging dogs and cats that are caused by prolonged exposure to second-hand tobacco smoke, herbicides, ultraviolet (UV) rays, pesticides, insecticides, and air pollution is further augmenting the market growth.

Moreover, the rising domestication of animals and the increasing awareness toward the benefits of timely diagnosis and available treatment options are also catalyzing the global market. Apart from this, various technological advancements, such as the introduction of highly specific and targeted therapies for animal cancer with minimal side effects, are acting as significant growth-inducing factors. Furthermore, the inflating expenditure capacities of the consumers on animal healthcare and the extensive research and development (R&D) activities in the field of veterinary oncology are anticipated to propel the pet cancer therapeutics market over the forecasted period.

Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

• AB Science (LON: 0Q77)
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated (NYSE: ELAN)
• ELIAS Animal Health LLC
• Karyopharm Therapeutics (NASDAQ: KPTI)
• Pfizer Inc.
• Regeneus Ltd. (ASX: RGS)
• Rhizen Pharmaceuticals AG
• Torigen Pharmaceuticals Inc.
• VetDC Inc.
• Virbac (EPA: VIRP)
• Zoetis In (LON: 0M3Q)

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Therapy:

• Chemotherapy
• Radiation Therapy
• Immunotherapy
• Combination Therapy
• Others

Breakup by Animal Species:

• Cats
• Dogs
• Others

Breakup by Cancer Type:

• Lymphoma
• Mast Cell Cancer
• Melanoma
• Mammary and Squamous Cell Cancer
• Others

Breakup by End User:

• Veterinary Hospitals and Clinical Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Explore Full Report Description At: https://www.imarcgroup.com/pet-cancer-therapeutics-market

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696